| | 1062169-56-5 Basic information More.. |
| Product Name: | WYE-354 | | Synonyms: | WYE-354;4-[6-[4-[(Methoxycarbonyl)amino]phenyl]-4-(4-morpholinyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinecarboxylic acid methyl ester;methyl 4-[6-[4-(methoxycarbonylamino)phenyl]-4-morpholin-4-ylpyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carboxylate;WYE-354 (Degrasyn);WYE-354;WYE 354; WYE354;Methyl 4-(6-(4-(methoxycarbonylamino)phenyl)-4-morpholino-1H-pyrazolo[3,4-d]pyrimidin-1-yl)pip;CS-441;1-Piperidinecarboxylic acid, 4-[6-[4-[(methoxycarbonyl)amino]phenyl]-4-(4-morpholinyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-, methyl ester | | CAS: | 1062169-56-5 | | MF: | C24H29N7O5 | | MW: | 495.53 | | EINECS: | | | Mol File: | 1062169-56-5.mol |  |
Use
A pyrazolopyrimidines derivative that is a potent and ATP-competitive mTOR inhibitor with much reduced activity against PI 3-Kα or PI 3-Kγ. WYE-354 is equally potent against mTORC1 and mTORC2 activities in HEK293 immune complex kinase assays using S6K and Akt as the respective substrate (IC50 <200 nM; [ATP] = 100 μM) and effectively blocks cellular phosphorylation of S6K on T389 and Akt on S473 both in cultures and in a murine xenograft model, resulting in a significant suppression of PC3MM2-derived tumor growth (by 86% on day 7; 50 mg/kg, i.p twice per day) in vivo.
- WYE-354
-
- US $43.00-158.00 / mg
- 2024-11-04
- CAS:1062169-56-5
- Min. Order:
- Purity: 99.61%
- Supply Ability: 10g
- WYE-354
-
- US $2.00 / kg
- 2019-07-06
- CAS:1062169-56-5
- Min. Order: 1kg
- Purity: 99%
- Supply Ability: ask
|
|
1062169-56-5
Recommend Suppliers |
|